Company profile: LeMaitre
1.1 - Company Overview
Company description
- Provider of medical devices and implants for the treatment of peripheral vascular diseases, including RestoreFlow, a tissue processing division supplying human tissue allografts for peripheral vascular and cardiac disease, and the LeMaitre Valvulotome, a device that cuts valves in peripheral veins without direct vision for lower extremity arterial disease.
Products and services
- Peripheral Vascular Devices & Implants: Engineers, fabricates, and markets medical-grade devices and implants for the treatment of peripheral vascular diseases, encompassing product development, manufacturing, and commercialization
- RestoreFlow®: Clinical-grade tissue processing division that delivers human tissue allografts for treatment of peripheral vascular and cardiac disease, providing processed allografts for vascular and cardiac therapeutic use
- LeMaitre Valvulotome: Surgical-grade instrument engineered to cut valves in peripheral veins without the need for direct vision, used in the treatment of lower extremity arterial disease.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LeMaitre
Tenaya Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage gene and small molecule therapies for heart diseases, including TN-201 for MYBPC3-associated hypertrophic cardiomyopathy, TN-401 for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, and TN-301, an HDAC6 inhibitor for heart failure with preserved ejection fraction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tenaya Therapeutics company profile →
Tangent Medical
HQ: United States
Website
- Description: Provider of intravenous catheters and associated products to improve infusion therapy for patients and healthcare workers, based on proprietary technology exclusively licensed from the University of Michigan's Medical Innovation Center; development-stage medical device company founded in Ann Arbor in 2009.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tangent Medical company profile →
Omeicos
HQ: Germany
Website
- Description: Provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omeicos company profile →
Advanced Catheter Therapies
HQ: United States
Website
- Description: Provider of catheter technologies for vascular disease, including thrombosis, inflammation, and occlusions, offering the Pressana Occlusion Perfusion Catheter for localized treatment delivery with controlled treatment chamber operations for various therapeutic agents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Catheter Therapies company profile →
Inovise
HQ: United States
Website
- Description: Provider of diagnostic medical technology focused on diagnostic cardiology, patient monitoring, and biomedical engineering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inovise company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LeMaitre
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LeMaitre
2.2 - Growth funds investing in similar companies to LeMaitre
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LeMaitre
4.2 - Public trading comparable groups for LeMaitre
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →